This double-blind, randomized, crossover trial aims to test the hypothesis that longer-term indoor air filtration intervention can slow atherothrombosis progression by reducing indoor fine particulate matter (PM2.5) exposure in adults with ischemic heart disease history.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in blood pressure
Timeframe: Blood pressure will be monitored daily during each of the 9-month intervention
Change in carotid-femoral pulse wave velocity
Timeframe: At the baseline, in the middle (4.5 month after intervention) and immediately after each of the 9-month interventions
Change in augmentation index
Timeframe: At the baseline, in the middle (4.5 month after intervention) and immediately after each of the 9-month interventions
Change in von Willebrand factor
Timeframe: At the baseline, in the middle (4.5 month after intervention) and immediately after each of the 9-month interventions
Change in P-selectin
Timeframe: At the baseline, in the middle (4.5 month after intervention) and immediately after each of the 9-month interventions